FDA Inspection 1327384 — Adare Pharmaceuticals Srl

Adare Pharmaceuticals Srl — FEI 1000573478

The FDA completed an inspection of Adare Pharmaceuticals Srl on June 6, 2025 in Pessano Con Bornago. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 6, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Pessano Con Bornago (Italy)

Additional Details

Mutual Recognition Agreement (MRA)